Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk


Autoria(s): Bingley, P.J.; Gale, E.A.M.; Carson, Dennis; Trial, The European Nicotinamide Diabetes Intervention
Data(s)

01/03/2006

Identificador

http://pure.qub.ac.uk/portal/en/publications/progression-to-type-1-diabetes-in-islet-cell-antibodypositive-relatives-in-the-european-nicotinamide-diabetes-intervention-trial-the-role-of-additional-immune-genetic-and-metabolic-markers-of-risk(25eb5e4b-dce5-45ff-9d8f-785c501f1aa4).html

http://dx.doi.org/10.1007/s00125-006-0160-4

http://www.scopus.com/inward/record.url?scp=33646401140&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Bingley , P J , Gale , E A M , Carson , D & Trial , T E N D I 2006 , ' Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk ' Diabetologia , vol 49(5) , no. 5 , pp. 881-890 . DOI: 10.1007/s00125-006-0160-4

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2712 #Endocrinology, Diabetes and Metabolism #/dk/atira/pure/subjectarea/asjc/2700/2724 #Internal Medicine
Tipo

article